Implications of MRI contrast enhancement following focal prostate cancer cryoablation.
The most compelling evidence that early CE is not indicative of prostate cancer recurrence is that all lesions resolved within 24 months. While incidence of early CE is low, its consistent resolution calls into question the clinical significance of this finding after PPGCA.
Authors
- James Steven Wysock (ORCID: https://orcid.org/0000-0002-7669-0947)
- Angela Tong (ORCID: https://orcid.org/0000-0002-4733-3414)
- Boris Y. Zaslavsky (ORCID: https://orcid.org/0000-0003-0771-6696)
- Eli Rapoport (ORCID: https://orcid.org/0000-0003-3430-3950)
- Jesse Persily (ORCID: https://orcid.org/0000-0002-6358-3333)
- Majlinda Tafa (ORCID: https://orcid.org/0009-0004-6788-9411)
- Herbert Lepor
Institutions
- NYU Langone Health (US)
Publication Details
- Journal
- PubMed
- Published
- 2024-10-01
- Primary Topic
- MRI in cancer diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00